Christoph Bredack

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Topics

Molecularly Imprinted

Cerebrospinal Fluid

Monoclonal Antibody

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Christoph Bredack, Martin R Edelmann, Edilio Borroni, Luca C Gobbi, Michael Honer
Antibody-Based In Vivo Imaging of Central Nervous System Targets-Evaluation of a Pretargeting Approach Utilizing a TCO-Conjugated Brain Shuttle Antibody and Radiolabeled Tetrazines. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Christoph Bredack, Martin R Edelmann, Edilio Borroni, Luca C Gobbi, Michael Honer
Antibody-Based In Vivo Imaging of Central Nervous System Targets-Evaluation of a Pretargeting Approach Utilizing a TCO-Conjugated Brain Shuttle Antibody and Radiolabeled Tetrazines. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Christoph Bredack, Martin R Edelmann, Edilio Borroni, Luca C Gobbi, Michael Honer
Antibody-Based In Vivo Imaging of Central Nervous System Targets-Evaluation of a Pretargeting Approach Utilizing a TCO-Conjugated Brain Shuttle Antibody and Radiolabeled Tetrazines. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Christoph Bredack, Martin R Edelmann, Edilio Borroni, Luca C Gobbi, Michael Honer
Antibody-Based In Vivo Imaging of Central Nervous System Targets-Evaluation of a Pretargeting Approach Utilizing a TCO-Conjugated Brain Shuttle Antibody and Radiolabeled Tetrazines. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)